Displaying 1 to 7 of 7 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Elevation Pharmaceuticals Inc |
United States | 1 Jan 2012 | Series B |
|
|
|
Elevation Pharmaceuticals Inc |
United States | 1 Sep 2011 | Series A |
|
|
|
Exagen Diagnostics Inc |
United States | 1 Sep 2012 | N/A Active |
|
|
|
LineaGen Inc Novel biomarkers company for the development of new diagnostic tests. |
United States | 1 Aug 2010 | Series A Active |
|
|
|
LineaGen Inc Novel biomarkers company for the development of new diagnostic tests. |
United States | 1 Jan 2011 | Series B Active |
|
|
Paradigm Diagnostics Inc |
United States | 16 Feb 2017 | Series B Active |
|
|
|
Traversa Therapeutics |
United States | 1 Apr 2009 | Series B Active |